FDA investigates heart attack, stroke risk from testosterone
Jan 31 (Reuters) - The U.S. Food and Drug Administration said on Friday it is investigating the risk of stroke, heart attack and death in men taking FDA-approved testosterone products.
The move is based on the recent publication of two separate studies that suggested an increased risk of heart attacks in men taking testosterone, a hormone essential to male growth.
Are you a newspaper subscriber but you don't have a Digital Access account yet? Activate your account.
You will need your subscription account number and phone number. Not sure if you have an account? Call 218-855-5897 and we can help you.